April 7, 2020
Biologic medications were introduced into the United States in 1982 and biosimilar medications in 2015.
November 25, 2019
Nearly 10 years ago, Congress created a pathway for lower-cost versions of breakthrough biologic drugs.
October 9, 2019
The controversial Institute for Clinical and Economic Review has done something unprecedented: admitted it’s wrong.
September 26, 2019
New data prove a point that clinicians and advocates have been making for years: Prior authorization hurts patients.
August 29, 2019
For someone with a flare-up of asthma symptoms, a short course of oral corticosteroids like prednisone can be a welcome relief. But when these potent medications become a regular remedy, asthma patients may have a problem.
July 2, 2019
Patients shouldn’t have to endure debilitating symptoms day after day when there is a medication that could help them.
June 3, 2019
Millions of Americans, including those with cancer and other life-threatening diseases, depend on Medicare for their medications. It’s an increasingly…
May 31, 2019
Migraine disease exists on a spectrum, presenting patients with different frequencies of attacks, whose duration and effect vary from person to person.
May 21, 2019
New guidance from the Food and Drug Administration explains what manufacturers must do to qualify their biosimilar medicine as interchangeable with its reference product.
May 9, 2019
One key to tracing how innovative biological medicines impact patients hinges on a deceptively simple issue: how the drugs are named.